640 filings
Page 12 of 32
DEFA14A
un2gzt pk
29 Aug 18
Additional proxy soliciting materials
12:00am
DEFA14A
85vdqxkxfv04otez
8 Aug 18
Additional proxy soliciting materials
4:52pm
8-K
8ae7i34bm
8 Aug 18
Ziopharm Oncology Reports Second Quarter 2018 Financial
4:07pm
8-K
z9cekdcsxajehkmp
27 Jul 18
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
7:30am
8-K
s37hffnnu5 49ao5epg
18 Jun 18
Ziopharm Oncology Reports on Status of Investigational New Drug Application for Phase 1 Trial to Evaluate CD19-targeted CAR T Therapy
7:40am
8-K
mr4ajtr o2braz
10 May 18
Ziopharm Oncology Reports First Quarter 2018 Financial Results and Provides Corporate Update
4:56pm
8-K
1xm5vdx 73oma
13 Mar 18
Departure of Directors or Certain Officers
12:00am
8-K
owpuqp rfzdcdn08
1 Mar 18
Ziopharm Oncology Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update
12:00am
8-K
vablsrjfc ja3my
22 Feb 18
Departure of Directors or Certain Officers
12:00am
8-K
7mtlk
6 Feb 18
Other Events
12:00am
8-K
1m8bcwgvyu fb0qwyks
5 Feb 18
Departure of Directors or Certain Officers
12:00am
8-K
vvnnfv
11 Jan 18
Regulation FD Disclosure
12:00am
8-K
7vuxcfwz4mxqce51bszj
9 Jan 18
Ziopharm Oncology Provides Update on Standout Technologies
12:00am
8-K
1ximzhvsl
6 Nov 17
ZIOPHARM Oncology Reports Third Quarter 2017 Financial Results and Provides Update on Recent Activities
12:00am